Valuation and Peers

Valuation and Peers

Figures converted from Indonesian Rupiah at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

At $0.12 JPFA trades on about 6.4x its record FY2025 earnings, 5.0x the trailing twelve months, and 5.8x forward consensus — cheap in absolute terms. But most of that cheapness is not JPFA's own: the entire Indonesian poultry complex has de-rated from 20–35x a few years ago to single digits, and JPFA sits mid-pack, at a persistent discount to sector leader CPIN. On mid-cycle rather than peak earnings, the discount shrinks to roughly 8.5x.

The price in numbers

Sources: share price and yield per market data, 3 August 2026; earnings per share $0.021 and net profit to owners $0.24bn from the FY2025 Annual Report [1]; market cap = $0.122 x 11.63bn shares.

JPFA's 11.63 billion shares at $0.122 give a market capitalisation of about $1.41bn against FY2025 net profit to owners of $0.24bn and earnings per share of $0.021 [2]. That is 6.4x reported FY2025 earnings. Because the first quarter of 2026 ran well ahead of the prior year, trailing-twelve-month earnings per share is nearer $0.024, which pulls the trailing multiple down to about 5.0x; consensus of $0.021 for FY2026 puts it at 5.8x forward. The shares are down roughly 17% from about $0.147 in early February and sit below their end-2025 level, so the multiple is falling on rising, not falling, earnings.

Against book value the picture is less dramatic. Total equity was $1.20bn at the end of 2025, of which $0.08bn belongs to non-controlling interests, leaving about $1.12bn attributable to JPFA's own shareholders [3]. At $1.41bn the shares trade at about 1.4x that equity — a fuller multiple than the P/E, because the P/E is being flattered by a return on equity (21.4% in FY2025) near the top of the cycle. Which of those two lenses is right depends on how durable the earnings are — the question the Segment Economics tab framed and this one prices.

A discount the whole sector wears

The instinct on a 6x P/E is to look for a company-specific reason the market is wrong. For JPFA, the more accurate starting point is that the market applies the low multiple to the whole Indonesian poultry sector. CPIN — the largest and best-capitalised of the group — offers the clearest record of the shift: it commanded 20–35x earnings through 2016–2023 and has since compressed to the low teens on 2025 earnings and roughly 7x trailing today.

Source: CPIN annual price-to-earnings ratios per market data (companiesmarketcap.com); trailing P/E of about 7x as of 3 August 2026 per market data.

The re-rating down has several plausible causes — the sector's cyclicality became undeniable after the 2022–2023 trough, the growth premium that once attached to a structural-consumption story faded, and Indonesian small-caps broadly de-rated. Whatever the mix, the effect is that a single-digit multiple is now the sector's resting state, not a JPFA anomaly. Within that band, the multiples line up by size and balance-sheet quality.

Sources: trailing P/E, price-to-book and dividend yield per market data, 3 August 2026 (StockAnalysis for IDX names; CPF ratios per market data). Market caps for IDX names in US dollars; CPF is Thailand-listed and shown for multiples only. JPFA P/B derived from shareholders' equity of $1.12bn [4].

The ladder is orderly. CPIN, the largest and least-levered, carries the highest multiple at about 7x trailing and 9x forward. JPFA sits below it at roughly 5x trailing. Malindo — the smallest and most volatile of the listed integrators — trades at about 3x. The regional cross-check, Thailand's Charoen Pokphand Foods, trades near 7x earnings and below book value at 0.8x. Nothing in this group is expensive; JPFA is neither the cheapest nor the dearest.

Why JPFA sits below the leader

The gap between JPFA at ~5x and CPIN at ~7x is not noise — it maps to real differences a buyer is entitled to discount for.

The first is the balance sheet. CPIN runs with modest leverage — roughly $0.15bn of net debt against $1.97bn of equity, a net-debt-to-equity ratio around 8% — and market forecasts have it moving to a net-cash position within a couple of years. JPFA carries about $0.50bn of net debt against $1.20bn of equity, and its US$350m Sustainability-Linked Bond fell due in March 2026, a maturity the Financials and Estimates tab showed pushed the current ratio to its weakest of the three years. The bond looks funded, but a levered cyclical is always worth less per unit of peak earnings than a near-unlevered one.

The second is mix and independence. CPIN's earnings lean more heavily on the stable, higher-return feed business; JPFA's profit swings more with the broiler and breeding layer, as the Segment Economics tab quantified. And JPFA sources a large share of its feed raw material through Annona Pte Ltd, an affiliate of its controlling group — a related-party channel the Ownership and the Parent tab found aligned but unbenchmarked. A minority buyer pays less for earnings that pass through a related party at a price they cannot independently verify.

The third is the control overhang. With the Santoso family holding 55.4% through a parent that was itself taken private and delisted in 2025, JPFA is now the only listed window into the group. That concentration cuts both ways — aligned incentives, but a standing question about minority treatment if the controller ever moved to consolidate. None of these three is fatal; together they explain why the market pays a leader's premium to CPIN and a discount to JPFA, and they are the levers a re-rating would have to move.

Which earnings you capitalise

The multiple a reader lands on depends on which year's earnings they treat as normal. JPFA's operating margin has ranged from 4.3% at the 2023 trough to 11.7% at the 2016 peak, averaging about 8.3% across the decade; FY2025's 10.2% sits in the upper part of that band [5]. Capitalise a mid-cycle 8% margin on FY2025 revenue and net profit to owners falls to roughly $0.17bn, or about $0.014 per share — and the multiple the reader is really paying rises accordingly.

Source: derived — $0.122 share price divided by earnings per share on each basis; reported EPS $0.005/$0.021 and revenue/margin from the FY2025 Annual Report [6]; mid-cycle EPS assumes an 8% operating margin on FY2025 revenue.

Left to right, the chart frames the valuation debate. If FY2023's trough is the true through-cycle earnings power, JPFA is expensive at nearly 28x. If the trailing figure — flattered by a hot first quarter — is durable, it is 5x. The mid-cycle estimate of about 8.5x is the most defensible anchor: it is what the stock costs on the decade's average margin rather than the trough or the peak. That is a reasonable, not a compelling, price for a controlled cyclical with a related-party input channel.

Consensus takes the more optimistic side. Thirteen analysts rate the stock Strong Buy with a mean target of $0.174, about 43% above the current price. At that target the shares would fetch roughly 8.3x FY2026 consensus and about 12x the mid-cycle earnings estimate — a level that requires both that earnings hold well above mid-cycle and that the sector multiple recovers some of the ground it lost. The target is a bet on the durable-earnings case the bulls make; it is not what today's price assumes.

Margin of safety

The downside is bounded more by the balance sheet and the dividend than by the multiple. On the mid-cycle earnings estimate the shares are about 8.5x — not a level that needs a re-rating to avoid loss, but not the deep discount the headline 5x suggests either. The 6.5% trailing dividend yield offers some support, but it is not a fixed coupon: JPFA's payout policy runs at roughly 35–55% of earnings and tracks the cycle, so in a trough year like 2023 (EPS $0.005) even a full payout would yield closer to 1.5% at today's price. The yield moves with the same margin that drives earnings.

The evidence points to a stock that is genuinely cheap on peak earnings and reasonably — not aggressively — priced on normalised earnings, carrying a discount that is mostly the sector's and partly its own for reasons a careful buyer would keep. The strongest fact against a bullish read is that FY2025's 10.2% margin sits near the top of the decade's range, so the base case should assume some mean reversion rather than extrapolate the record. The read would change if the mid-2026 half-year statement showed the feed and broiler margins holding into a second year — evidence that the supply-managed cycle has lifted mid-cycle earnings power structurally, which would make even 8x normalised earnings look low — or, on the other side, if the margin began reverting toward the 6–8% band while the sector multiple stayed compressed, which would leave today's price fair rather than cheap.